Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (13)	10/30/1998 3:46:00 PM
From: j_fir2	Respond to of 1386

So many of biotech companies crash and burn. When I first looked into Pars I was impressed that the price didn't have the volatility that most of the others in biotech (and elsewhere) have. Unless you bought on the spikes, you haven't lost real money in PARS. Given the market as a whole this year, and the biotech market in general and lately-- this is a pretty pain-free stock to told. True--it was $2 three years ago too--o.k. But this is a penny stock! If you want year after year 8% appreciation, get out of small cap biotechs! At least we know we can walk away from this stock (truly! We don't have to check every day!) and know it (and our money) is in good--nay, excellent hands.